Notably, in postmortem studies on AD-affected brains, TG2- and TG2-catalyzed covalent isodipeptide bonds co-localize with tau-positive NFT in the hippocampus and neocortex [130,138]. This evidence concerns the gene TGM2 and Alzheimer disease.